placebo pill

Preclinical

placebo pill is one of 2 therapeutic programs targeting Orthostatic; Hypotension, Neurogenic. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Orthostatic; Hypotension, NeurogenicRecruiting

Orthostatic; Hypotension, NeurogenicPreclinical

Recruiting

Competition

Competitive Landscape

1 competitor in Orthostatic; Hypotension, Neurogenic

#DrugCompanyPhaseTrials

Midodrine or Atomoxetine Pill

VVanderbilt University Medical Center

Preclinical

1 2

placebo pill

VVanderbilt University Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Orthostatic; Hypotension, Neurogenic

NCT04782830

Clinical

Trials by Indication[1]

Orthostatic; Hypotension, Neurogenic1 trial

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Recruiting·VVanderbilt University Medical Center·Preclinical·NCT04782830·29 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for placebo pill. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for placebo pill. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Vanderbilt University Medical Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: VVanderbilt University Medical Center

placebo pill

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Orthostatic; Hypotension, Neurogenic1 trial

References

Drug Info

Quick Facts

Related News